Publicaciones (27) Publicaciones en las que ha participado algún/a investigador/a

2018

  1. Abatacept in patients with rheumatoid arthritis and interstitial lung disease: A national multicenter study of 63 patients

    Seminars in Arthritis and Rheumatism, Vol. 48, Núm. 1, pp. 22-27

  2. Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Behçet's disease: Multicentre retrospective study

    Rheumatology (United Kingdom), Vol. 57, Núm. 5, pp. 856-864

  3. Biologic Disease-modifying antirheumatic drug attributes in the first lines of treatment of rheumatoid arthritis. 2015 ACORDAR project

    Reumatologia Clinica, Vol. 14, Núm. 2, pp. 90-96

  4. Blau Syndrome–Associated Uveitis: Preliminary Results From an International Prospective Interventional Case Series

    American Journal of Ophthalmology, Vol. 187, pp. 158-166

  5. Brief Report: Validation of a Definition of Flare in Patients With Established Gout

    Arthritis and Rheumatology, Vol. 70, Núm. 3, pp. 462-467

  6. Correction to: The beliefs of rheumatoid arthritis patients in their subcutaneous biological drug: strengths and areas of concern (Rheumatology International, (2018), 38, 9, (1735-1740), 10.1007/s00296-018-4097-y)

    Rheumatology International

  7. Defective glucose and lipid metabolism in rheumatoid arthritis is determined by chronic inflammation in metabolic tissues

    Journal of Internal Medicine, Vol. 284, Núm. 1, pp. 61-77

  8. Improvement in Diagnosis and Treat-to-Target Management of Hyperuricemia in Gout: Results from the GEMA-2 Transversal Study on Practice

    Rheumatology and Therapy, Vol. 5, Núm. 1, pp. 243-253

  9. Improving adherence to gout therapy: An expert review

    Therapeutics and Clinical Risk Management, Vol. 14, pp. 793-802

  10. International position paper on the appropriate use of uricosurics with the introduction of lesinurad

    Clinical Rheumatology, Vol. 37, Núm. 12, pp. 3159-3165

  11. La réponse rénale aux variations de l'uricémie est différente chez les patients goutteux comparativement aux sujets sains

    Revue du Rhumatisme (Edition Francaise), Vol. 85, Núm. 1, pp. 79-84

  12. Long-term etanercept survival in patients with psoriatic arthritis: a multicenter retrospective analysis in daily clinical practice in Spain

    Rheumatology International, Vol. 38, Núm. 11, pp. 2037-2043

  13. Peripheral B-cell subset distribution in primary antiphospholipid syndrome

    International Journal of Molecular Sciences, Vol. 19, Núm. 2

  14. Primary respiratory disease in patients with systemic lupus erythematosus: Data from the Spanish rheumatology society lupus registry (RELESSER) cohort

    Arthritis Research and Therapy, Vol. 20, Núm. 1

  15. Recommendations for the use of methotrexate in psoriatic arthritis

    Reumatologia Clinica, Vol. 14, Núm. 4, pp. 183-190

  16. Recommendations for the use of parenteral methotrexate in rheumatic diseases

    Reumatologia Clinica, Vol. 14, Núm. 3, pp. 142-149

  17. S100A12 and S100A8/9 proteins are biomarkers of articular disease activity in Blau syndrome

    Rheumatology (United Kingdom), Vol. 57, Núm. 7, pp. 1299-1304

  18. SAT0622 High dose intravenous methylprednisolone induces rapid improvement in severe uveitis: a multicenter study of 129 patients

    Annals of the Rheumatic Diseases, Vol. 77, pp. 1162-1163

  19. Serum drug levels of biologic agents in the management of rheumatoid arthritis and spondyloarthritis: a systematic review

    Rheumatology International, Vol. 38, Núm. 6, pp. 975-983

  20. Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease

    Ophthalmology, Vol. 125, Núm. 9, pp. 1444-1451